Synchroneuron Receives $6,000,000 Series A Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    Undisclosed Waltham, MA 02451
  • Company Description
    Synchroneuron Inc., a Waltham, Mass.-based biopharmaceutical company that develops new therapies for tardive dyskinesia (TD) and other related movement disorders.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company did not state what it intended to do with the funds, but it did note that it expects to start Phase 1 clinical trials this year for a new drug therapy to treat Tardive dyskinesia.
  • M&A Terms
  • Venture Investor
    Morningside Group

Trending on Xconomy